Patent Assignment
Reel/Frame 011392/0561
Assignment of Assignor's Interest
Recorded: 2001-01-03
Pages: 3
Assignor
CANFIELD, WILLIAM E.
Executed: 2000-12-15
Assignee
NOVAZYME PHARMACEUTICALS, INC.
800 RESEARCH PARKWAY, SUITE 200, OKLAHOMA CITY, OKLAHOMA, 73014
Covered Property
(1)
Gicnac Phosphotransferase of the Lysosomal Targeting Pathway
Patent:
6,642,038 →
Application:
09/636,060 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrected Recordation Form Cover Sheet to Correct Assignor's Name and Address, Previously Recorded at Reel/Frame 011392/0561. (Assignment of Assignor's Interest)
May 16, 2001
From: CANFIELD, WILLIAM M.
To: NOVAZYME PHARMACEUTICALS, INC.
Reel/Frame 011811/0859 →
Change of Name
Nov 27, 2002
From: NOVAZYME PHARMACEUTICALS, INC.
To: GENZYME GLYCOBIOLOGY RESEARCH INSTITUTE, INC.
Reel/Frame 013537/0101 →
Merger
Jan 24, 2006
From: GENZYME GLYCOBIOLOGY RESEARCH INSTITUTE, INC.
To: GENZYME CORPORATION
Reel/Frame 017207/0425 →